TickerFacts.

Neuroone Medical Technologies Corp (NMTC): Cost of Revenue

Annual figures by period end, from SEC filings.

$3.96M
Year ended 2025-09-30
$4.20M
Trailing 12 months to 2026-06-30
+153.8%
3-year compound annual growth
2021-09-30: $275.9K2022-09-30: $242.0K2023-09-30: $1.50M2024-09-30: $2.37M2025-09-30: $3.96M$3.96M
2021-09-30 Cost of Revenue (USD) 2025-09-30
Period endedCost of RevenueChange YoYSource filing
2025-09-30$3.96M+66.7%2025-12-17, From 2024-10-01
2024-09-30$2.37M+58.7%2025-12-17, From 2023-10-01
2023-09-30$1.50M+518.2%2024-12-17, From 2022-10-01
2022-09-30$242.0K-12.3%2023-12-15, From 2021-10-01
2021-09-30$275.9Kn/a2022-12-22, From 2020-10-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Neuroone Medical Technologies Corp (NMTC)2025-09-30$3.96M+66.7%
InspireMD, Inc. (NSPR)2025-12-31$6.33M+15.0%
Medinotec Inc. (MDNC)2026-02-28$4.60M+7.1%
Beyond Air, Inc. (XAIR)2026-03-31$7.43M+38.4%
Nexgel, Inc. (NXGL)2025-12-31$6.91M+16.4%
INVO Fertility, Inc. (IVF)2025-12-31$30.6K+150.6%
Encision Inc (ECIA)2025-03-31$3.04M-11.8%
Allurion Technologies, Inc. (ALUR)2025-12-31$5.66M-46.6%
Biotricity Inc. (BTCY)2026-03-31$3.05M-5.5%

Compare NMTC, NSPR, MDNC, XAIR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗